ArticleMolecular therapy. Oncology2026
Safety and feasibility of talimogene laherparepvec in peritoneal surface malignancies: Results from the TEMPO trial.
John H Stewart et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it